Drug Discovery

#Animal models #Drug development #Drug discovery #The Jackson Laboratory #Vodcast

New vodcast on AI-powered home cage monitoring

The latest sponsored DDW Sitting Down With vodcast features Michael Ellis, Senior Director of R&D at The Jackson Laboratory (JAX), and Timothy Robertson, CEO of TLR Ventures and Leader of the Digital In Vivo Alliance to introduce their new digital home cage monitoring system, Envision. Both Ellis and… Read More

#News

#Drug development #Drug discovery #Interview #Sitting Down With #The Jackson Laboratory #Vodcast

Vodcast: Revolutionising preclinical research with AI-powered home cage monitoring

The latest sponsored DDW Sitting Down With vodcast features Michael Ellis, Senior Director of R&D at The Jackson Laboratory (JAX), and Timothy Robertson, CEO of TLR Ventures and Leader of the Digital In Vivo Alliance to introduce their new digital home cage monitoring system, Envision. Both Ellis and… Read More

#Videos

#Artificial intelligence (AI) #BenevolentAI #Business #Drug discovery

BenevolentAI announces layoffs as it plans to delist and refocus

BenevolentAI has unveiled a major strategic overhaul, which it says will return the company to its founding TechBio mission.   The company has initiated significant organisational and budgetary changes that extend into 2027 and is also exploring options to delist from Euronext Amsterdam.  Kenneth Mulvany, Executive… Read More

#Business & Investment #News #Trending News

#Drug discovery

Webinar: Characterization of CAR-T cells: Integrating live-cell analysis and high-throughput cytometry – Sartorius – 05.12.2024

The development of gene-modified cell therapies, particularly CAR-T cells, has transformed cancer treatment by offering personalized and potentially curative options.  This webinar, hosted by DDW and supported by Sartorius, explores the integration of live-cell analysis and high-throughput screening (HTS) by cytometry to enhance the characterization of CAR-T cells. Key topics… Read More

#Webinars

#Artificial intelligence (AI) #CAR-T #Drug discovery #Exosomes #Oncology #Weight loss

New DDW Highlights podcast: 9 December 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week’s leading news stories all shine a light on… Read More

#News

#Artificial intelligence (AI) #CAR-T #Drug discovery #Exosomes #Oncology #Weight loss

This week in drug discovery (2-6 December) 

News round-up for 2-6 December by DDW Senior Digital Content Editor Diana Spencer. This week’s leading news stories all shine a light on innovation within drug discovery, including a potential ‘best-in-industry’ weight loss drug, a gold-based compound that shrinks tumours by 82%, and a second-generation CAR-T therapy. Read More

#News

#Collaboration #Drug development #Drug discovery #Partnership

Nine collaborations driving drug discovery forward in Q4

Diana Spencer compiles a list of the research partnerships that will have a significant impact on the development of new drugs into 2025. Dutch Oncode Institute and Cancer Research Horizons The Dutch Oncode Institute and Cancer Research Horizons formed a strategic alliance during a recent Dutch economic mission to… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Alzheimer's #Automation #Biomarkers #Data automation #Data management #Digital biomarkers #Digitalisation #Drug development #Drug discovery #Genetics / genomics #Mass spectrometry / NMR #Neurodegenerative disorders #Neuroscience

New podcast: The far-reaching impact of drug discovery technology

This is the latest episode of the free DDW narrated podcast, titled “The far-reaching impact of drug discovery technology”, which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “Accelerating time to market through digitalisation”, “… Read More

#News

AI and genomics
#Artificial intelligence (AI) #Automation / robotics #Events #Lab technology #SLAS2024

Expertise on automating discovery with AI: Join DDW at SLAS2025

Another high profile speaker has signed up to the DDW SLAS track – Nicola Richmond, Chief Scientist, AI, Recursion. Nicola Richmond Richmond will be speaking at DDW‘s track – Concept to Cure: Curiosity and Lab Automation in Drug Discovery at SLAS2025 (25-29 January 2025, San… Read More

#News

#Drug discovery

Webinar: Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro – bit.bio – 03.12.2024

In this webinar hosted by DDW and supported by bit.bio, Dr Stephen Ferguson, Investigator, Mechanistic Toxicology, Division of Translational Toxicology (DTT), National Institute of Environmental Health Sciences, will explore the complexities of in vitro modelling for human liver toxicity and pharmacology. He will discuss the development and implementation of advanced… Read More

#Webinars

Exosomes
#Drug discovery #EXO Biologics #Exosomes #GMP

Two industry-first milestones for the exosome field

EXO Biologics (and its CDMO subsidiary, ExoXpert) has announced it has received Good Manufacturing Practice (GMP) certification for its manufacturing plant in Liège, Belgium.  In addition, the company says it has managed to achieve the loading of GMP-grade exosomes with mRNA and DNA payloads, describing it as… Read More

#News

#Drug discovery

eBook: Optimize Your Preclinical Research with Genetically Engineered Mouse Models

This guide explores key considerations for generating and managing genetically engineered mouse models (GEMs) to accelerate and optimize preclinical research programs. Generating GEMs: three cutting-edge technologies you need to know. Five key components of effective colony management. How integrated solutions can unlock the full potential of preclinical research. Read More

#eBooks

#Cancer research #Drug development #Drug discovery #Immune system #Immunotherapy #Life sciences #Lithuania #Oncology #Start-ups #Tumour biology #Tumours

New podcast: Exciting start-ups and developments in drug discovery

This is the latest episode of the free DDW narrated podcast, titled ‘Exciting start-ups and developments in drug discovery’, which covers two articles written for DDW Volume 24 – Issue 1, Winter 2022/2023. They are called: ‘What Lithuania offers life sciences start-ups’ and ‘… Read More

#News

Conference speaker
#Automation / robotics #Events #Lab technology #SLAS2025 #Translational chemistry

Learn about realising real time translational science at SLAS2025

The latest speaker to the DDW SLAS track is Alexander G Godfrey, Automation Consultant, ASPIRE Scientific Lead, National Center for Advancing Translational Sciences (NCATS). Alexander G Godfrey Godfrey will be speaking at DDW‘s track – Concept to Cure: Curiosity and Lab Automation in Drug Discovery at SLAS2025 (25-29 January… Read More

#News

#Drug development #Investment #Life sciences #Treehill Partners #US government

Expert opinion on life sciences in a Trump/RFK era

Max Baumann, Co-Founder and Head of Execution of Treehill Partners, discusses what investors, drug developers, and the rest of the life science sector can do to prepare for the Trump/RFK era. The arrival of a new US administration generates significant industry-wide speculation and anticipation regarding new policies and agendas that may… Read More

#Business & Investment #Exclusive Content #Opinion